Trial Profile
A study of BB-001 in patients with B-cell lymphoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs BB 001 (Primary)
- Indications B-cell lymphoma
- Focus Adverse reactions
- 07 Jul 2016 New trial record
- 12 Sep 2013 According to a Bullet Biotechnology media release, the company is planning to start this study in the year 2015.